RaymondDMengMD

Oncology • New York, NY

Physician

Join to view full profile

Dr. Meng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meng's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-2000

Fax+1 646-422-0631

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Duke University HospitalResidency, Internal Medicine, 2001 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2001

Certifications & Licensure

NY State Medical License 2004 - 2011

Publications & Presentations

PubMed

68 citations
A Randomized Controlled Trial of a Cardiopulmonary Resuscitation Video in Advance Care Planning for Progressive Pancreas and Hepatobiliary Cancer Patients
Andrew S. Epstein, Angelo E. Volandes, Ling Y. Chen, Kristen Gary, Yuelin Li
Journal of Palliative Medicine. 2013-05-31
18 citations
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with...
Geoffrey I. Shapiro, Patricia LoRusso, Daniel C. Cho, Luna Musib, Yibing Yan
Investigational New Drugs. 2021-02-01
121 citations
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors.
Cristina Saura, Desamparados Roda, Susana Roselló, Mafalda Oliveira, Teresa Macarulla
Cancer Discovery. 2017-01-01